Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon May 01, 2018 8:09am

100 Views

Post# 27963056

RE:RE:RE:RE:Clinically cancer free ! ! ! :)

vestor111 wrote: With the inflammation on P4, they may have reduced the absorption time with the higher concentration of the higher dose. Healthy cells still absorb the compound so perhaps they had to tweak the exposure period. Just speculating.

But whatever they did, it appears to be working. Phenomenal news!

As of the clinical trials 20 April update which indicates that the therapeutic dose was not modified, your supposition of reduced apsorption time looks to be a valid one.

Bullboard Posts

Eminent acquires promising Nevada gold project